Reed Finishes 13th In New Hampshire
LOUDON, N.H. (July 18, 2015) – Roush Fenway Racing driver Ryan Reed and the No. 16 Lilly Diabetes American Diabetes Association team finished 13th on Saturday at New Hampshire Motor Speedway (NHMS) after starting 21st and making adjustments to move up through the field.
“I would say we salvaged a decent finish today,” said Reed. “We don’t come to the race track to finish 13th; however I’m really proud of my No. 16 Lilly Diabetes American Diabetes Association team for all the hard work. Whether we’re going to finish 17th or win the race, we’re going to dig for every spot we can get. It’s just about having heart and soul and getting all you can get.”
Reed started the 200-lap event from the 21st position and quickly gained four positions within the first three laps of the race. By the first caution flag on Lap 17, Reed was up to the 17th position and told crew chief Seth Barbour that the car wasn’t bad, but he was a little tight in the center of the turns.
By the second caution on lap 22, Reed was up to 15th position and was not reporting any issues with the car. He restarted 14th on Lap 28 and continued to gain position. He was up to 12th by the time the third caution flag flew on Lap 36 and told the team the car was still tight in the center. Crew chief Seth Barbour brought his driver down pit road under the caution period for right-side tires and a full tank of fuel.
Reed restarted in the 13th position and had settled in 14th by the time the next caution flag flew on Lap 57. He reported that the car needed right-side grip, but was otherwise decent. The team elected not to pit during the caution and waited until the Lap 121 green-flag pit stop to make adjustments. Barbour called for a wedge adjustment and four tires to correct Reed’s tight condition.
By the time that pit stops had cycled through, Reed held on to the 18th position and reported the car needed rear grip. He was up to 15th by the Lap 141 caution flag and stayed out to maintain track position.
By the final caution flag on Lap 164, Reed was up to 14th and battled with teammate Chris Buescher for position. The field restarted for the final time on Lap 174 with Reed in 13th. He maintained his position for the remaining 25 laps to record his 12th top-15 finish of the season.
Reed moves up to ninth in the NASCAR XFINITY Series championship standings after Saturday’s race at NHMS. He and the No. 16 team return to the track on Saturday, July 25 at Indianapolis Motor Speedway for the Lilly Diabetes 250.
Roush Fenway Racing is the winningest team in NASCAR history, fielding multiple teams in NASCAR Sprint Cup Series and NASCAR XFINITY Series competition with drivers Greg Biffle, Ricky Stenhouse Jr., Trevor Bayne, Elliott Sadler, Ryan Reed, Chris Buescher and Bubba Wallace. Now in its 28th season, Roush Fenway is a leader in driver development, having launched the careers for many of the top drivers in the sport. Off-track, Roush Fenway is a leader in NASCAR marketing solutions, pioneering motorsport’s first team-focused TV show and producing multiple award-winning digital and experiential marketing campaigns. Roush Fenway is co-owned by Jack Roush, the winningest team owner in NASCAR history and Fenway Sports Group, parent company of Major League Baseball’s Boston Red Sox and English Premier League’s Liverpool F.C. Visit RoushFenway.com, circle on Google+, become a fan on Facebookand Instagram and follow on Twitter at @roushfenway.
About The American Diabetes Association
The American Diabetes Association is leading the fight to Stop Diabetes and its deadly consequences and fighting for those affected by diabetes. The Association funds research to prevent, cure and manage diabetes; delivers services to hundreds of communities; provides objective and credible information; and gives voice to those denied their rights because of diabetes. For the past 75 years, our mission has been to prevent and cure diabetes and to improve the lives of all people affected by diabetes. For more information please call the American Diabetes Association at 1-800-DIABETES (1-800-342-2383) or visit www.diabetes.org. Information from both these sources is available in English and Spanish.
About Lilly Diabetes
Lilly has been a global leader in diabetes care since 1923, when we introduced the world’s first commercial insulin. Today we are building upon this heritage by working to meet the diverse needs of people with diabetes and those who care for them. Through research and collaboration, a broad and growing product portfolio and a continued determination to provide real solutions—from medicines to support programs and more—we strive to make life better for all those affected by diabetes around the world. For more information, visit www.lillydiabetes.com or follow us on Twitter: @LillyDiabetes.